Jeff Jonker, Belharra Therapeutics CEO
February 29, 2024 02:30 PM ESTUpdated 06:07 PM
Pharma
Marketing

Bel­har­ra CEO talks the ins and outs of build­ing a biotech in a new pod­cast

Beth Snyder Bulik

Senior Editor

Bel­har­ra Ther­a­peu­tics CEO Jeff Jonker wants to lift the cur­tain on the world of biotech star­tups. His new pod­cast, “Birth of a Biotech,” tells Bel­har­ra’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times